Medical Marijuana Inc (MJNA)

[Art Vandeley]

Temple University – Animal Behavioral/Pre-Clinical Model
On May 1, 2014, Kannalife™ signed a Research Services Agreement with Temple University to
test the effects of cannabidiol and cannabidiol like molecules in a hepatic encephalopathy model
of cognitive impairment in support of the identification of compounds with in vivo efficacy. The
tests to be performed by Temple University will involve a mouse model of hepatic
encephalopathy and administration of CBD or CBD analogues to be conducted by Dr. Sara Jane
Ward with the study titled – “Cognitive, neurological, and motor function in a mouse model of
hepatic encephalopathy: effects of CBD and CBD analogues.”

http://www.otcmarkets.com/financialReportViewer?symbol=MJNA&id=127115